FATE · Fate Therapeutics Inc
$2.57
+0.05 (+1.98%)
At close · Aug 14
Market Cap
$307.94M
Shares
119.82M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2011-12-31 | $7,000 | 10-K, filed 2014-03-17 |
Key facts
CIK
1434316
CUSIP
31189P102
13F (30d)
145 filings
144 filers
Visit website
Investor relations